IFN-γ production by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells

Journal of Hepatology

Volumn 59, Issue 3, 2013, Pages 442-449

  Zhang, Shuye ^a,b,c   Saha, Banishree ^a   Kodys, Karen ^a   Szabo, Gyongyi ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b FUDAN UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

IFN ; Monocyte; NK; pDC

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; HLA DR ANTIGEN; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2;

ACCESSORY CELL; ARTICLE; CELL POPULATION; CYTOKINE PRODUCTION; DENDRITIC CELL; HEPATITIS C; HEPATOMA CELL; IMMUNOCOMPETENT CELL; LYMPHOCYTE FUNCTION; MONOCYTE; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; T CELL DEPLETION; THROMBOCYTE FUNCTION;

DC; DENDRITIC CELL; ELISA; ENZYME-LINKED IMMUNOSORBENT ASSAY; HCV; HEPATITIS C VIRUS; IFN; IFN-Α; INTERFERON; INTERFERON STIMULATED GENE; ISG; MDC; MONOCYTE; MYELOID DENDRITIC CELL; NATURAL KILLER; NATURAL KILLER T; NK; NKT; PAMPS; PATHOGEN ASSOCIATED MOLECULAR PATTERNS; PBMC; PCR; PDC; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMACYTOID DENDRITIC CELL; POLYMERASE CHAIN REACTION; TLR; TOLL-LIKE RECEPTOR;

ANIMALS; CELL LINE, TUMOR; COCULTURE TECHNIQUES; DENDRITIC CELLS; HEPACIVIRUS; HEPATITIS C; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INTERFERON TYPE I; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LIVER NEOPLASMS, EXPERIMENTAL; MONOCYTES;

EID: 84882843581     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2013.04.022     Document Type: Article

References (28)

1. D. Thomas, and F. Zoulim New challenges in viral hepatitis Gut 61 2012 i1 i5
2. S.M. Lemon Induction and evasion of innate antiviral responses by hepatitis C virus J Biol Chem 285 2010 22741 22747
3. G. Ahlenstiel, B. Edlich, L.J. Hogdal, Y. Rotman, M. Noureddin, and J.J. Feld Early changes in natural killer cell function indicate virologic response to interferon therapy for hepatitis C Gastroenterology 141 2011 1231 1239 1239 e1231-e1232
4. B. Amadei, S. Urbani, A. Cazaly, P. Fisicaro, A. Zerbini, and P. Ahmed Activation of natural killer cells during acute infection with hepatitis C virus Gastroenterology 138 2010 1536 1545
5. B. Edlich, G. Ahlenstiel, A.Z. Azpiroz, J. Stoltzfus, M. Noureddin, and E. Serti Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients Hepatology 55 2012 39 48
6. B. Oliviero, S. Varchetta, E. Paudice, G. Michelone, M. Zaramella, and D. Mavilio Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections Gastroenterology 137 2009 1151 1160 1160 e1151-e1157
7. O. Dessouki, Y. Kamiya, H. Nagahama, M. Tanaka, S. Suzu, and Y. Sasaki Chronic hepatitis C viral infection reduces NK cell frequency and suppresses cytokine secretion: reversion by anti-viral treatment Biochem Biophys Res Commun 393 2010 331 337
8. G. Ahlenstiel, R.H. Titerence, C. Koh, B. Edlich, J.J. Feld, and Y. Rotman Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner Gastroenterology 138 2010 325 335 e321-e322
9. L. Golden-Mason, A.L. Cox, J.A. Randall, L. Cheng, and H.R. Rosen Increased natural killer cell cytotoxicity and NKp30 expression protects against hepatitis C virus infection in high-risk individuals and inhibits replication in vitro Hepatology 52 2010 1581 1589
10. S. Pelletier, C. Drouin, N. Bedard, S.I. Khakoo, J. Bruneau, and N.H. Shoukry Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses J Hepatol 53 2010 805 816
11. E. Vivier, D.H. Raulet, A. Moretta, M.A. Caligiuri, L. Zitvogel, and L.L. Lanier Innate or adaptive immunity? The example of natural killer cells Science 331 2011 44 49
12. R. Barreira da Silva, and C. Munz Natural killer cell activation by dendritic cells: balancing inhibitory and activating signals Cell Mol Life Sci 68 2011 3505 3518
13. K.C. Newman, and E.M. Riley Whatever turns you on: accessory-cell- dependent activation of NK cells by pathogens Nat Rev Immunol 7 2007 279 291
14. F. Gerosa, A. Gobbi, P. Zorzi, S. Burg, F. Briere, and G. Carra The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions J Immunol 174 2005 727 734
15. J.C. Yoon, J.B. Lim, J.H. Park, and J.M. Lee Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells J Virol 85 2011 12557 12569
16. J.C. Yoon, M. Shiina, G. Ahlenstiel, and B. Rehermann Natural killer cell function is intact after direct exposure to infectious hepatitis C virions Hepatology 49 2009 12 21
17. K. Takahashi, S. Asabe, S. Wieland, U. Garaigorta, P. Gastaminza, and M. Isogawa Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection Proc Natl Acad Sci U S A 107 2010 7431 7436
18. S. Zhang, K. Kodys, G.J. Babcock, and G. Szabo CD81/CD9 tetraspanins aid plasmacytoid dendritic cells in recognition of HCV-infected cells and induction of IFNalpha Hepatology 2012 10.1002/hep.25827
19. S. Chang, K. Kodys, and G. Szabo Impaired expression and function of toll-like receptor 7 in hepatitis C virus infection in human hepatoma cells Hepatology 51 2010 35 42
20. A. Poli, T. Michel, M. Theresine, E. Andres, F. Hentges, and J. Zimmer CD56bright natural killer (NK) cells: an important NK cell subset Immunology 126 2009 458 465
21. M. Dreux, U. Garaigorta, B. Boyd, E. Decembre, J. Chung, and C. Whitten-Bauer Short-range exosomal transfer of viral RNA from infected cells to plasmacytoid dendritic cells triggers innate immunity Cell Host Microbe 12 2012 558 570
22. W.E. Carson, M.E. Ross, R.A. Baiocchi, M.J. Marien, N. Boiani, and K. Grabstein Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro J Clin Invest 96 1995 2578 2582
23. K. Yamaji, S. Nabeshima, M. Murata, Y. Chong, N. Furusyo, and H. Ikematsu Interferon-alpha/beta upregulate IL-15 expression in vitro and in vivo: analysis in human hepatocellular carcinoma cell lines and in chronic hepatitis C patients during interferon-alpha/beta treatment Cancer Immunol Immunother 55 2006 394 403
24. N.H. Shoukry, S. Pelletier, and K.M. Chang A view to natural killer cells in hepatitis C Gastroenterology 141 2011 1144 1148
25. S. Crotta, M. Brazzoli, D. Piccioli, N.M. Valiante, and A. Wack Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection J Hepatol 52 2010 183 190
26. U. Protzer, M.K. Maini, and P.A. Knolle Living in the liver: hepatic infections Nat Rev Immunol 12 2012 201 213
27. C. Okuse, J.A. Rinaudo, K. Farrar, F. Wells, and B.E. Korba Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy Antiviral Res 65 2005 23 34
28. S.Y. Zhang, S. Boisson-Dupuis, A. Chapgier, K. Yang, J. Bustamante, and A. Puel Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense Immunol Rev 226 2008 29 40